The pharmacokinetics of d-t1tbocurarine 1£'as studied in man during single and multiple admil1istrations of d-tubocurarine, al/d in dogs during single administrations. The simplest model consistent with our data was a fleo-compartment open model. The mean half-lives for the tl£'O phases in the hwnan studies lure 8·9 and 123·8 minutes. For the greyhounds these mean l'alues were 2·8 and 77·4 minutes. The animals did not demonstrate a difference bet1£'een the arterial and mixed venolls concentratiolls of d-tubocurarine.
Despite its clinical use for more than thirty years, there is still a considerable intcrest in d-tubocurarine, not only in the pharmacological responses, hut also in the kinetics of its absorption, distribution, excretion and metaholism. :\Icthods of measurcment of the plasma conccntrations of non-depolarising muscle relaxants have improved, and include fluorimetric assay of d-tubocurarine and pancuronium (Cohcn 19f1:{, Kersten, :\Ieijer and Agoston 1973) , and radioimmunoassay for d-tubocurarine (Horowitz and Spector~1973) . Thesc developments have encouraged studics to be made in man during anaesthcsia, examining the pharmacokinetics of the relaxants and the relationships to the degree of neuromuscular blockade.
:\Iatteo, Spector and Horowitz (1974) reported a highly significant linear correlation hetween the serum concentration of d-tubocurarine and the evoked twitch tension. Twitch tension started to recover at a mean serum d-tubocurarine concentration of O· 70 p.g/ml, and this had fallen to a mean of 0 ·45 p.g/ml at 50% recovery. Wingard and Cook (1976) reworked the data obtained from five patients by Horowitz and Spector (1973) and described the mathematical pharmacokinetics of d-tubocurarine following a single intravenous injection.
Our study was intended to evaluate the pharmacokinetics of d-tubocurarine and to extend it into an examination of multiple administration. It also examines the distribution of d-tubocurarine between the venous and arterial plasma as a guide to sequestration of the drug by the lung.
i.IETHODS
Human stlldies
These involved adult patients undergoing routine general anaesthesia for elective surgery. They weighed 55-] 01 kg and had body surface areas of ]. 62-2· 05m 2 • They were premedicated with a combination of a narcotic analgesic and atropine or hyoscine. Anaesthesia was induced with thiopentone, and maintained with a mixture of nitrous oxide, oxygen and 0·5 % halothane. Each patient received an initial intravenous bolus injection of d-tubocurarine equivalent to 20 mg/m 2 of body surface area, a dose which totalled between 30 and 45 mg, and represen ted a range of 0 ·47 to 0 . 65 mg/kg. Group A consisted of 7 patients who received only this single injection. Group B consisted of 3 patients who required additional doses of d-tubocurarine, either a quarter or a half of the initial dose, according to clinical requirements.
Plasma for the estimation of d-tubocurarine concentrations was collected from a central venous catheter whose tip was within the thorax. Venous blood samples were collected at 5, 10, 15, 20,30 and 45 minutes and again at 1, It, 2, 3, 4, Anaesthesia and Intensive Care, Vol. VI, No. 1, February, 1978 and where possible 5 hours. In Group B, when successive doses were required, the sampling programme was recommenced.
Animal studies
Four unpremedicated greyhounds were anaesthetized with intravenous sodium pentobarbitone 30 mg/kg supplemented as required to maintain unconsciousness. After endotracheal intubation, the animals were ventilated passively with a mixture of air and oxygen sufficient to maintain their end-expired carbon dioxide between 20 and 30 mmHg. Under fluoroscopic control, catheters were placed in the carotid artery, right atrium and the main pulmonary artery. An 8-channel (Sanborn 350) recorder displayed gas flow in the airway, ECG, pressures in the carotid artery, right atrium and pulmonary artery, and evoked twitch tension. Isotonic saline was infused to help maintain blood pressure, and an intravenous bolus injection of d-tubocurarine O· 4 mg/kg was administered. Lower oesophageal and limb temperatures were held between 37° and 39°C. Neuromuscular block was examined by means of a Grass FT-03 force displacement transducer attached to the transected tendon of tibialis or gastrocnemius muscle. Supramaximal stimuli were applied at 0 . 2 Hz to the isolated transected sciatic nerve, and a stable twitch response was elicited from each animal for an hour prior to the injection of d-tubocurarine.
Blood samples were taken simultaneously from the carotid and pulmonary arteries. Two to five samples were taken during the first ten minutes, thereafter following a similar schedule to the human studies.
d-Tubocurarine analysis and computation
All blood samples were collected into heparinised tubes, and were centrifuged immediately. The plasma was removed and stored at once at -4°C until assayed. The method of analysis was a modification of that described by Cohen (1963) with fluorescences measured on a Perkin-Elmer 204 Fluorescence Spectrophotometer. This procedure allowed estimates of d-tubocurarine concentration as low as O' 05 [Lg/ml.
The plasma concentration-time curve for our data was fitted in turn to equations for biexponential (two-compartment) or tri-exponential equations, by means of an iterative least-squares nonlinear regression programme NONLIN (Metzler 1969) using a CDC CYBER 72 computer system. All of the individual data were weighted according to the reciprocal of the square of the plasma concentration normalised to the sum of the number of data points. The F-ratio test as described by Boxenbaum et al. (1974) was used to test whether or not the weighted sums of squared deviations had been sufficiently reduced to justify fitting with additional parameters. This was accomplished by:
where WSS j is the weighted sums of squared deviations obtained with the jth set of parameters, WSS k is the weighted sums of squared deviations obtained with the kth set of parameters, and df is degrees of freedom and is equal to the number of data points used to fit the curve(s) minus the number of parameters fitted (dfj>df k ). The calculated F was compared to the critical value (5% level of significance), and if the calculated value was lower than the value from the table, it was concluded that the weighted sums of squared deviations were not significantly different.
Assessment of satisfactory convergence of the programme was performed in each case by using the final computer parameter estimates as initial values for a second iteration when no further reduction in weighted sums of squared deviations occurred.
RESULTS
A typical plot of the observed plasma concentrations for a patient in Group A is shown in Figure 1 , and superimposed upon this are the lines of the computer-predicted multicompartment models. The results obtained by fitting the two-and three-compartment models are shown in Tables 1 and 2. No significant reduction in the sums of weighted squared deviations were noted for the combined 11 sets of data indicating that the simplest model consistent with our results was a two-compartment model.
A typical example of a plasma concentrationtime plot for a patient in Group B is shown in Figure 2 . Table 2 summarises some of the pharmacokinetic parameters obtained from the computer fits. With Group B the initial value for slope alpha was estimated from the first portion of the plasma level-time plot, while the initial value for slope beta was obtained from the terminal portion of each curve. The rate constants, after pooling the data for all patients, were alpha 0·0782±0·0344 (S.D.) per minute, and beta 0·0056±0·00l4 (S.D.) per minute. The half-life of the distribution phase for all the patients was 8·86±3·90 (S.D.) minutes, and the half-life for the pseudo-elimination phase was 123·75:!-=30·94 (S.D.) minutes. For the greyhounds, these mean values were 2·8 and 77·4 minutes respectively. The apparent volume of distribution of the central (or sampling) compartment was determined for the patients b\' the ratio of the do~e of cl-tubocurarine to the sum of ,\+B (computed e~timates of zero-time intercepts), and was found to be 170:;:59 (S.D.) ml/kg. The greyhounds showcd a return of twitch response at a mean of :!7 minutes and a rccm'ery inclex (Feldman 1H74) a\'Craging:!O minutes. There was a lincar decline, in the per cent paralysis (compared with the control value) with time for all three greyhounds. The mean slope (rate of decline) of the lines was found to be DISCl'SS]():\
1, Human stztdics
The simplest pharmacokinetic model consistent with the plasma dTC-time data in humans was found to be a two-compartment open model. This satisfied statistical methods suggested by Boxcnbaum et al. (1974) and ma\' explain the difference with the model depictecl by Gibaldi et al. (197:!) and Wingarcl and Cook (1 H7()). Both groups suggested the necessity of using a three-exponential equation to fit cl-tubocurarine Allaesthesia alld /niCllsive Carf, Vol. VI, .\'0, J, February, 1978 a WSSR is the weighted sums of squared residuals.
b This subject showed the highest F ratio, 4·92, which is not significant at the 5 per cent level as it is less than the critical value for p=0·05: F 2 ,.=5·79. plasma level-time data. The latter authors obtained the equation of best fit as :
The half-life values obtained from the three exponentials are 0'9, 9·8 and 152 minutes respectively, and the latter two values are comparable with our alpha and beta half-lives of 10·7 and 130 minutes respectively. The results from Gibaldi et al. (1972) compare less favourably.
The apparent volume of distribution of the central compartment was found to be about 170 ml/kg, a value far larger than that calculated by both of the other groups of workers.
The two-compartment open model was able to characterize adequately the plasma concentration-time data obtained from patients receiving multiple doses of the drug, the nonlinear fitting of these being in good agreement with those from Group A. These patients were given d-tubocurarine at initial dosages just in excess of 0·6 mg/kg. Wingard and Cook (1976) suggested that the fraction of d-tubocurarine bound to tissue may increase with such doses, resulting in a corresponding increase in the apparent volume of distribution. However, in our three Group B patients, there was no concomitant evidence of cumulation, and they followed a similar pattern to that shown in Figure 2 . Pittinger, Morris and Cullen (1951) reported plasma concentrations in one patient to whom a second dose of curare was administered, and which resulted in a prolonged increase in the concentration. Feldman (1973) suggested that, as receptor occupancy by the drug was more important than its plasma concentration, a single large dose would be preferable to a mUltiple low dose regime, the latter producing a high blood level at the end of the operation.
Animal studies
Although too few for adequate statistics, our data from the greyhounds show good agreement by Walts and Dillon (1968) . Our findings in the greyhounds are in agreement with findings of :\Iatteo et al. (l!l7 -!) who reported a highly significant linear correlation hetween serum concentration of d-tubocurarine and twitch tension. When challenged by Feldman (1975) , Matteo (1975) suggested that this correlation was ..
0·9094 0·2210
0·1388 0·0007 observable during the recovery phase of neuromuscular blockade, because it examined factors operating in the whole body after an equilibrium had been reached between concentrations of d-tubocurarine at the endplate, in the extracellular fluids, and in the serum. The plasma concentration-time data in greyhounds was adequately characterized by a two-compartment open model. Cohen et al. (1965) intravenous administration of 0·3 mg/kg of d-tubocurarine, and the rate constants are in good agreement. The half-life of the distribution phase was 2·8 minutes in greyhounds and 3·1 minutes in mongrel dogs, while the half-life of the elimination phase was calculated to be 64·3 minutes in the mongrel as compared to 77 ·4 minutes in greyhounds.
In humans Cohen et al. (1957) showed a difference in the arterial and venous concentra-tions of d-tubocurarine, suggesting that well perfused organs, such as lung, might take up a significant fraction of d-tubocurarine administered intravenously. However, in our study with greyhounds, there was no difference between the arterial and the mixed venous concentrations of d-tubocurarine.
